Vitals Pharmaceuticals acquires eisai Pharmaceuticals
Vitals (NYSE: VES) (NASDAQ: VET) and eisale (NASD: EIS) announced a definitive merger on Tuesday that will see the merged company acquire all of the assets of the eisakay pharmaceuticals company.In an exclusive interview with Business Insider, Vitals CEO Amit Gupta said the deal is a testament to eisake’s ability to rapidly grow their product…